Company Overview of Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. develops formulates pharmaceuticals for treatment of osteoporosis. It develops ZT-034, a nasal spray formulation of teriparatide that offers an alternate for patients at high risk of fracture. The company was formerly known as Zelos Therapeutics, Inc. and changed its name to Azelon Pharmaceuticals, Inc. in April 2004. Azelon Pharmaceuticals, Inc. was founded in 2000 and is based in West Conshohocken, Pennsylvania.
200 Barr Harbor Drive
Four Tower Bridge
West Conshohocken, PA 19428
Founded in 2000
Key Executives for Azelon Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Azelon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.